Schwartz JL - Search Results

1

Future of covid-19 vaccine pricing: lessons from influenza.

Ramachandran R, Dhodapkar M, Ross JS, Schwartz JL. Ramachandran R, et al. Among authors: schwartz jl. BMJ. 2021 Jun 22;373:n1467. doi: 10.1136/bmj.n1467. BMJ. 2021. PMID: 34158283 No abstract available.

2

Vaccine Pricing and US Immunization Policies.

Schwartz JL. Schwartz JL. JAMA. 2016 Jul 12;316(2):226. doi: 10.1001/jama.2016.6307. JAMA. 2016. PMID: 27404201 No abstract available.

3

Association Between Food and Drug Administration Advisory Committee Recommendations and Agency Actions, 2008-2015.

Zhang AD, Schwartz JL, Ross JS. Zhang AD, et al. Among authors: schwartz jl. Milbank Q. 2019 Sep;97(3):796-819. doi: 10.1111/1468-0009.12403. Epub 2019 Jul 14. Milbank Q. 2019. PMID: 31304643 Free PMC article.

4

Speed, Evidence, and Safety Characteristics of Vaccine Approvals by the US Food and Drug Administration.

Puthumana J, Egilman AC, Zhang AD, Schwartz JL, Ross JS. Puthumana J, et al. Among authors: schwartz jl. JAMA Intern Med. 2021 Apr 1;181(4):559-560. doi: 10.1001/jamainternmed.2020.7472. JAMA Intern Med. 2021. PMID: 33170923 Free PMC article.

5

Clinical Outcomes Of A COVID-19 Vaccine: Implementation Over Efficacy.

Paltiel AD, Schwartz JL, Zheng A, Walensky RP. Paltiel AD, et al. Among authors: schwartz jl. Health Aff (Millwood). 2021 Jan;40(1):42-52. doi: 10.1377/hlthaff.2020.02054. Epub 2020 Nov 19. Health Aff (Millwood). 2021. PMID: 33211536 Free PMC article.

6

Equitable global access to coronavirus disease 2019 vaccines.

Schwartz JL. Schwartz JL. BMJ. 2020 Dec 15;371:m4735. doi: 10.1136/bmj.m4735. BMJ. 2020. PMID: 33323384 No abstract available.

7

Speed Versus Efficacy: Quantifying Potential Tradeoffs in COVID-19 Vaccine Deployment.

Paltiel AD, Zheng A, Schwartz JL. Paltiel AD, et al. Among authors: schwartz jl. Ann Intern Med. 2021 Apr;174(4):568-570. doi: 10.7326/M20-7866. Epub 2021 Jan 5. Ann Intern Med. 2021. PMID: 33395345 Free PMC article. No abstract available.

8

Demographic Characteristics of Participants in Trials Essential to US Food and Drug Administration Vaccine Approvals, 2010-2020.

Zhang AD, Puthumana J, Egilman AC, Schwartz JL, Ross JS. Zhang AD, et al. Among authors: schwartz jl. J Gen Intern Med. 2022 Feb;37(3):700-702. doi: 10.1007/s11606-021-06670-3. Epub 2021 Mar 3. J Gen Intern Med. 2022. PMID: 33660209 Free PMC article. No abstract available.

9

Characteristics of Preapproval and Postapproval Studies of Vaccines Granted Accelerated Approval by the US Food and Drug Administration.

Egilman A, Wallach JD, Puthumana J, Zhang AD, Schwartz JL, Ross JS. Egilman A, et al. Among authors: schwartz jl. J Gen Intern Med. 2021 Oct;36(10):3281-3284. doi: 10.1007/s11606-021-06943-x. Epub 2021 Jun 15. J Gen Intern Med. 2021. PMID: 34131876 Free PMC article. No abstract available.

10

Assessing COVID-19 Prevention Strategies to Permit the Safe Opening of Residential Colleges in Fall 2021.

Paltiel AD, Schwartz JL. Paltiel AD, et al. Among authors: schwartz jl. Ann Intern Med. 2021 Nov;174(11):1563-1571. doi: 10.7326/M21-2965. Epub 2021 Aug 31. Ann Intern Med. 2021. PMID: 34461034 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

595 results

Search Page